BDMD SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Jul 27, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 24, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

May 15, 2025

NT 20-F

Form NT 20-F - Notification of inability to timely file Form 20-F

Apr 30, 2025

News

TYPE

HEADLINE

FILED AT

6-K

Baird Medical Receives Nasdaq Minimum Bid Price Deficiency Notification

Nov 5, 2026

6-K

Baird Medical Enters into Securities Purchase Agreement for Senior Convertible Promissory Note

Sep 30, 2026

6-K

Baird Medical Investment Holdings Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026

Sep 30, 2026

6-K

Baird Medical Reports 25% Revenue Growth and Positive Net Income for First Half of 2026

Sep 3, 2026

6-K

Baird Medical Investment Holdings Limited Changes Independent Auditor

Feb 10, 2026

6-K

Baird Medical Investment Holdings Limited Releases unaudited interim condensed consolidated financial statements for the six months ended June 30, 2025

Dec 5, 2025

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Sep 24, 2026

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Aug 18, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 45,915,562

Jan 16, 2026

425

Form 425 - Prospectuses and communications, business combinations

Sep 5, 2024

424B3

Sep 5, 2024

425

Form 425 - Prospectuses and communications, business combinations

Mar 18, 2024

Registrations

TYPE

HEADLINE

FILED AT

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)

Oct 1, 2026

ExcelFin SPAC LLC (Reporting)

Jul 31, 2026

SCHEDULE 13D

ExcelFin SPAC LLC (Filed by)

Jul 31, 2026

SCHEDULE 13G

Alta Partners LLC (Filed by)

May 8, 2026

Xu Lijian (Reporting)

Apr 21, 2026

Qiu Quan (Reporting)

Apr 21, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Aug 18, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Aug 18, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 16, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 6, 2024

CORRESP

Form CORRESP - Correspondence

Sep 3, 2024

CORRESP

Form CORRESP - Correspondence

Aug 26, 2024

Baird Medical Investment Holdings Limited BDMD · SEC Filings